Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Today marks Nurses' Day 2022. This year's theme is #BestofNursing, so we chatted to some of our amazing Research Nurses about what the Best of Nursing means to them.

The Nurses team at NDORMS posing with their arms crossed.

Alice Harin

Alice Harin, Research Nurse 

Nursing is about making a difference to patients, being their advocate and supporting them throughout their “journey”. Here is a testimony from one of my patients:

“It certainly has been a journey, and honestly Alice I am so glad I signed up for the trials because it has been great having your support, I don't know if I would have felt quite so positive if I felt alone on this journey!”

 

Susan Morris, Clinical Research Nurse  

There are lots of care stories that could be shared within the framework of #BestofNursing. Reflecting on my own personal experiences over the last few years, it is hard to select just one snapshot of care.  

As research Nurses we have such a diverse role, we are not just recruiting patients or managing trials. Research nursing is an autonomous, challenging role, which blends science and care, so that patients can either manage their disease symptoms with trial drugs or be part of the greater good for future research and new treatments.

We strive to be non-judgemental, compassionate and ensure we deliver a high standard of care, I have seen examples of this throughout the COVID pandemic. We were challenged with different opinions on vaccination and treatments from the media, and my colleagues kept focused and recognised patient’s individual opinions and needs.

I am proud to be a Research nurse. #BestofNursing.

‘Let us never consider ourselves finished nurses… we must be learning all of our lives’

Florence Nightingale

 

Gail Lang, Research Manager  

Kassim Javaid, Sue Davis, Shauna Masters and Pam Lovegrove Kassim Javaid, Sue Davis, Shauna Masters and Pam Lovegrove

I would like to recognise Shauna Masters and Pam Lovegrove for the brilliant nursing care given over a four year study of burosumab in X-linked hypophosphatemia (XLH; an inherited disease where the body doesn't maintain phosphorus and that leads to softening of bones). Working with Associate Professor Kassim Javaid, Shauna and Pam supported our patient Sue Davis enabling her to be part of the study, a huge commitment on her part, with regular complex study visits and multiple investigations.  This has meant she has improved her quality of life and contributed to this novel new treatment being approved in the US and presently in children in the UK. 

Similar stories

Yoshi Itoh wins the International Dupuytren Award 2022

Yoshi Itoh, Associate Professor and Principal Investigator Cell Migration Group at the Kennedy Institute has been awarded the International Dupuytren Award 2022.

Taking a break from immune-suppressing medicines doubles the antibody response to COVID-19 booster vaccination

The Oxford Clinical Trials Research Unit (OCTRU) at NDORMS played a key role in the VROOM study which found that pausing immune-suppressing medicines such as methotrexate can increase the response to COVID-19 booster jabs.

Ten Years of Athena Swan in the Medical Sciences Division

2022 marks ten years since the first Athena Swan Bronze applications from the Medical Sciences Division. Ten years later, and all 16 departments in the Division have achieved a Silver Award. We look at NDORMS’ Athena Swan journey.

NDORMS researchers awarded Associate Professor title

The University of Oxford has awarded the title of Associate Professor to Adam Cribbs and Luke Jostins.

Oxford's largest ever study into varicose veins shows need for surgery is linked to genetics

A new international study by Oxford researchers published in Nature Communications, establishes for the first time a critical genetic risk score to predict the likelihood of patients suffering with varicose veins to require surgery, as well as pointing the way towards potential new therapies.

Reflecting on the role of Clinical Director of Trauma and Orthopaedics

In 2021 Professor Andrew Price was appointed Clinical Director of Trauma and Orthopaedics at the Oxford University Hospitals NHS Foundation Trust. After 9 months in post, we find out what the challenges are and what he’s been able to bring to the role.